Postmenopausal endogenous oestrogens and risk of endometrial cancer: Results of a prospective study

British Journal of Cancer

Volumn 84, Issue 7, 2001, Pages 975-981

  Zeleniuch Jacquotte, A ^a   Akhmedkhanov, A ^a   Kato, I ^b   Koenig, K L ^a   Shore, R E ^a   Kim, M Y ^a   Levitz, M ^a   Mittal, K R ^a   Raju, U ^a   Banerjee, S ^a   Toniolo, P ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Body mass index; Endometrial cancer; Nested case control study; Oestradiol; Oestrogen; SHBG

Indexed keywords

ESTRADIOL; ESTROGEN; ESTRONE; SEX HORMONE BINDING GLOBULIN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; HEIGHT; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN;

EID: 17744376755     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1704     Document Type: Article

References (36)

1. Chromatographic purification of estradiol 17B for use in radio-ligand assay
2. Plasma extrogen in patients with endometrial hyperplasia and carcinoma
3. Analysis of case-control data with covariate measurement error: Application to diet and colon cancer
4. Endometrial cancer, obesity and body fat distribution
5. Plasma levels of fractionated estrogens and pituitary hormones in endometrial carcinoma
6. Estradiol, androstenedione, testosterone and dehydroepiandrosterone sulfate in the ovarian and peripheral blood of postmenopausal patients with and without endometrial cancer
7. Free estradiol in postmenopausal women with and without endometrial cancer
8. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities
9. Proliferation kinetics of human endometrium during the normal menstrual cycle
10. Endocrine factors in the etiology of endometrial carcinoma
11. Reproducibility of plasma hormone levels in postmenopauseal women over a 2-3 year period
12. Endogenous hormones as a major factor in human cancer
13. Estrone sulphate plasma levels in postmenopausal women with and without endometrial cancer
14. Serum 17,β-estradiol and estrone levels in postmenopausal women with and without endometrial cancer
15. Serum androgens and estrogens in postmenopausal women with and without endometrial cancer
16. Comparison of active and cancer registry-based follow-up for breast cancer in a prospective cohort study
17. The dose-effect relationship between unopposed estrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk
18. Longitudinal data analysis using generalized linear models
19. Biased selection of controls for case-control analyses of cohort studies
20. Does body mass index adequately capture the relation of body composition and body size to health outcomes?
21. Radioimmunoassay of plasma estrogens. Use of polymerized antibodies
22. Serum SHBG capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma
23. Plasma oestrogens in postmenopausal women with endometrial cancer
24. Serum estrogens and androgens in women with endometrial carcinoma
25. Estrogen-progestin replacement therapy and endometrial cancer
26. Case-control study of endogenous steroid hormones and endometrial cancer
27. Measurement error does not explain the persistence of a body mass index association with endometrial cancer after adjustment for endogenous hormones
28. Theories of endometrial carcinogenesis: A multidisciplinary approach
29. Steroid hormones and endometrial cancer
30. Sources of variability in waist and hip measurements in middle-aged women
31. Endogenous hormones and breast cancer: A prospective cohort study
32. Reliability of measurements of total, protein-bound, and unbound estradiol in serum
33. A prospective study of endogenous estrogens and breast cancer in postmenopausal women
34. Hormone levels in healthy postmenopausal women and women with postmenopausal bleeding with and without endometrial carcinoma
35. Risk of endometrial cancer following estrogen replacement with and without progestins